医療ガバナンス研究所
理事長上昌広SNS
製薬マネー論文
Undisclosed Conflicts of Interest in Japanese Cancer Clinical Trials: A Cross-Sectional Study of Author-Pharmaceutical Industry Financial Relationships
No.
Date:
Title:
87
Authors:
Murasawa H, Shin N, Miyata H, Saito C, Tanimoto T, Saito H, Hakariya H, Mintzes B, Ozaki A
First Author:
Murasawa H
Journal/Book:
JCO Oncol Pract
URL:
Awareness of Financial Conflicts of Interest in Selecting Clinical Practice Guidelines Among Nepalese Oncologists: A Cross-Sectional Study
No.
Date:
Title:
86
Authors:
Shrestha R, Ozaki A, Saito H, Tsubokura M, Tanimoto T, Ghimire B, Singh YP, Sapkota S, Shrestha S
First Author:
Shrestha R
Journal/Book:
J Eval Clin Pract
URL:
Increasing trends of pharmaceutical payments to breast cancer specialists in Japan: A retrospective study from 2016 to 2019
No.
Date:
Title:
83
Authors:
Kaneda Y, Yamashita E, Saito H, Gonda K, Wada M, Tanimoto T, Ozaki A
First Author:
Kaneda Y
Journal/Book:
PLoS One
URL:
Reassessing physician interactions with pharmaceutical companies: A response to Murayama et al. and analysis of survey discrepancies
No.
Date:
Title:
85
Authors:
Ozaki A, Saito H, Endo M, Takebayashi Y, Murakami M
First Author:
Ozaki A
Journal/Book:
Int J Health Plann Manage
URL:
The challenge for drug shortage: lessons learned from the quality issues of Japanese generic drug companies
No.
Date:
Title:
84
Authors:
Hashimoto T, Ozaki A, Saito H, Yamashita E, Tanimoto T, Jakovljevic M
First Author:
Hashimoto T
Journal/Book:
GaBI Journal
URL:
Unveiling, Analyzing the Mechanisms of, and Proposing Solutions for Bribery in Japan's Medical Device Sector
No.
Date:
Title:
82
Authors:
Ozaki A, Larkin J, Sakata N, Kaneda Y, Yamashita E, Saito H, Tanimoto T, Jakovljevic M
First Author:
Ozaki A
Journal/Book:
Cureus
URL:
Reporting Conflicts of Interest and Funding in Health Care Guidelines: The RIGHT-COI&F Checklist
No.
Date:
Title:
81
Authors:
Xun Y, Estill J, Khabsa J, Florez ID, Guyatt GH, Norris SL, Lee MS, Ozaki A, Qaseem A, Schünemann HJ, Shao R, Chen Y, Akl EA, RIGHT-COI&F Working Groups (Saito H, et all)
First Author:
Xun Y
Journal/Book:
Ann Intern Med
URL:
Association Between Gender and Payments Received From Pharmaceutical Companies Among Medical Professors and Associate Professors in Japan
No.
Date:
Title:
80
Authors:
Miura M, Tanimoto T, Saito H, Yamamoto K, Yamashita E, Ozaki A
First Author:
Miura M
Journal/Book:
Cureus
URL:
Payments to healthcare organisations reported by the medical device industry in Europe from 2017 to 2019: an observational study
No.
Date:
Title:
78
Authors:
Larkin J, Mulinari S, Ozieranski P, Lynch K, Fahey T, Ozaki A, Moriarty F
First Author:
Larkin J
Journal/Book:
Health Policy and Technology
URL:
Nature and Trend of Pharmaceutical Payments to Japanese Board-Certified Neurologists Between 2016 and 2019: A Pre-emergence Analysis Amidst the Development of Next-Generation Alzheimer’s Disease Drugs
No.
Date:
Title:
77
Authors:
Shrestha R, Saito H, Yamashita E, Shrestha S, Tanimoto T, Ozaki A
First Author:
Shrestha R
Journal/Book:
Cureus
URL:
Public database on pharmaceutical ties in Japan: Traffic and user attitudes on industry-professional relationships
No.
Date:
Title:
79
Authors:
Suzuki Y, Murayama A, Ozaki A, Saito H, Sawano T, Yamashita E, Tanimoto T
First Author:
Suzuki Y
Journal/Book:
Health Policy and Technology
URL:
Japanese Physicians' Perceptions of Conflicts of Interest with Pharmaceutical Companies: estimating two different questioning approaches
No.
Date:
Title:
76
Authors:
Saito H, Ozaki A, Murakami M, Takebayashi Y
First Author:
Saito H
Journal/Book:
Int J Health Plann Manage
URL:
Association between Conflicts of Interest Disclosure and Quality of Clinical Practice Guidelines in Japan: A Meta-Epidemiological Study
No.
Date:
Title:
75
Authors:
Yamamoto N, Ozaki A, Taito S, Ariie T, Someko H, Saito H, Tanimoto T, Kataoka Y
First Author:
Yamamoto N
Journal/Book:
JPM
URL:
Characteristics of Top-Searched Individuals in Japan’s Yen for Docs Conflicts of Interest Database During the COVID-19 Pandemic
No.
Date:
Title:
74
Authors:
Kaneda Y, Ozaki A, Hashimoto T, Suzuki Y, Saito H, Tanimoto T, Yamashita E, Jakovljevic M
First Author:
Kaneda Y
Journal/Book:
Cureus
URL:
Assessment of Financial Relationships Between Otorhinolaryngologists and Pharmaceutical Companies in Japan Between 2016 and 2019
No.
Date:
Title:
73
Authors:
Kamamoto S, Ozaki A, Murayama A
First Author:
Kamamoto S
Journal/Book:
Cureus
URL:
Reshaping landscape of Japanese generics market – uncertain future of universal health insurance
No.
Date:
Title:
72
Authors:
Kosaka M, Ozaki A, Kaneda Y, Saito H, Yamashita E, Murayama A, Mamada H, Tanimoto T, Jakovljevic M
First Author:
Kosaka M
Journal/Book:
GENERICS AND BIOSIMILARS INITIATIVE
URL:
Characteristics and Distribution of Scholarship Donations From Pharmaceutical Companies to Japanese Healthcare Institutions in 2017: a Cross Sectional Analysis
No.
Date:
Title:
71
Authors:
Murayama A, Kamamoto K, Saito H, Yamashita E, Suzuki Y, Tanimoto T, Ozieranski P, Ozaki A
First Author:
Murayama A
Journal/Book:
IJHPM
URL:
Research and Nonresearch Industry Payments to Nephrologists in the United States between 2014 and 2021
No.
Date:
Title:
70
Authors:
Murayama A, Kamamoto S, Kugo H, Saito H, Ozaki A
First Author:
Murayama A
Journal/Book:
J Am Soc Nephrol
URL:
Financial conflicts of interest between pharmaceutical companies and executive board members of internal medicine subspecialty societies in Japan between 2016 and 2020
No.
Date:
Title:
69
Authors:
Murayama A, Saito H, Tanimoto T, Ozaki A
First Author:
Murayama A
Journal/Book:
J Eval Clin Pract
URL:
Generic drug crisis in Japan and changes leading to the collapse of universal health insurance established in 1961: the case of Kobayashi Kako Co. Ltd.
No.
Date:
Title:
68
Authors:
Kosaka M, Ozaki A, Kaneda Y, Saito H, Yamashita E, Murayama A, Mamada H, Tanimoto T, Jakovljevic M
First Author:
Kosaka M
Journal/Book:
Cost Effectiveness and Resource Allocation
URL:
Gender Disparities in Medical Industry Payments
No.
Date:
Title:
67
Authors:
Shin N, Ozaki A, Tanimoto T
First Author:
Shin N
Journal/Book:
JAMA Surg
URL:
Pharmaceutical payments to Japanese board-certified dermatologists: a 4-year retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019
No.
Date:
Title:
66
Authors:
Murayama A, Kamamoto S, Saito H, Ozaki A
First Author:
Murayama A
Journal/Book:
Sci Rep
URL:
Cross-sectional analysis of pharmaceutical payments to Japanese board-certified gastroenterologists between 2016 and 2019
No.
Date:
Title:
65
Authors:
Murayama A, Kamamoto S, Kawashima M, Saito H, Yamashita E, Tanimoto T, Ozaki A
First Author:
Murayama A
Journal/Book:
BMJ Open
URL:
A Nine-year Investigation of Healthcare Industry Payments to Pulmonologists in the United States
No.
Date:
Title:
58
Authors:
Murayama A, Kugo H, Saito Y, Saito H, Tanimoto T, Ozaki A
First Author:
Murayama A
Journal/Book:
Ann Am Thorac Soc
URL:
Evaluation of Financial Conflicts of Interest and Quality of Evidence Underlying the American Diabetes Association Clinical Practice Guidelines: The Standards of Medical Care in Diabetes, 2021
No.
Date:
Title:
59
Authors:
Shigeta H, Murayama A, Kamamoto S, Saito H, Ozaki A
First Author:
Shigeta H
Journal/Book:
cureus
URL:
Research and Nonresearch Industry Payments for COVID-19 mRNA Vaccines in the United States
No.
Date:
Title:
64
Authors:
Murayama A, Kamamoto S, Saito H, Tanimoto T, Ozaki A
First Author:
Murayama A
Journal/Book:
JMA Journal
URL:
International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency
No.
Date:
Title:
61
Authors:
Ozieranski P, Saito H, Rickard H, Mulinari S, Ozaki A
First Author:
Ozieranski P
Journal/Book:
Global Health
URL:
Pharmaceutical Payments to Japanese Board-Certified Head and Neck Surgeons Between 2016 and 2019
No.
Date:
Title:
63
Authors:
Murayama A, Shigeta H, Kamamoto S, Yamashita E, Saito H, Sawano T, Bhandari D, BPharm SS, Kusumi E, Tanimoto T, Ozaki A
First Author:
Murayama A
Journal/Book:
OTO Open
URL:
Japan's valsartan clinical trials shambles; time for fundamental changes
No.
Date:
Title:
62
Authors:
Ozaki A, Harada K, Murayama A, Saito H, Sawano T, Tanimoto T, Shrestha S, Bhandari D, Crump A
First Author:
Ozaki A
Journal/Book:
Int J Health Plann Manage
URL:
Evaluation of non-research payments from pharmaceutical companies to urologists in Japan between 2016 and 2019
No.
Date:
Title:
60
Authors:
Murayama A, Saito H, Kamamoto S, Shigeta H, Yamashita E, Tanimoto T, Ozaki A
First Author:
Murayama A
Journal/Book:
Int Urogynecol J
URL:
Observational study of financial and non-financial conflicts of interest among the Japanese government advisory board members concerning coronavirus disease 2019
No.
Date:
Title:
57
Authors:
Mamada H, Murayama A, Ozaki A, Hashimoto T, Saito H, Sawano T, Yamashita E, Bhandari D, Shrestha S, Tanimoto T
First Author:
Mamada H
Journal/Book:
Medicine (Baltimore)
URL:
Industry payments during the COVID-19 pandemic for cardiologists in the United States
No.
Date:
Title:
56
Authors:
Murayama A, Kamamoto S, Shigeta H, Ozaki A
First Author:
Murayama A
Journal/Book:
CJC Open
URL:
The Trend in Industry Payments During the COVID-19 Pandemic Among Gastroenterologists and Hepatologists in the United States
No.
Date:
Title:
55
Authors:
Murayama A, Kamamoto S, Saito H, Tanimoto T, Ozaki A
First Author:
Murayama A
Journal/Book:
Cureus Journal of Medical Science
URL:
Trends in Industry Payments to Diabetologists and Endocrinologists in the United States During the COVID-19 Pandemic
No.
Date:
Title:
54
Authors:
Murayama A, Kamamoto S, Saito H, Tanimoto T, Ozaki A
First Author:
Murayama A
Journal/Book:
Cureus Journal of Medical Science
URL:
Evaluation of Financial Conflicts of Interest and Quality of Evidence in Japanese Gastroenterology Clinical Practice Guidelines
No.
Date:
Title:
53
Authors:
Murayama A, Kamamoto S, Murata N, Yamasaki R, Yamada K, Yamashita E, Saito H, Tanimoto T, Ozaki A
First Author:
Murayama A
Journal/Book:
J Gastroenterol Hepatol
URL:
Financial Relationships Between Pharmaceutical Companies and Rheumatologists in Japan Between 2016 and 2019
No.
Date:
Title:
52
Authors:
Murayama A, Mamada H, Shigeta H, Yoshinaga T, Saito H, Yamashita E, Tanimoto T, Ozaki A
First Author:
Murayama A
Journal/Book:
Journal of Clinical Rheumatology
URL:
Nature and Trends in Personal Payments Made to the Respiratory Physicians by Pharmaceutical Companies in Japan between 2016 and 2019
No.
Date:
Title:
51
Authors:
Murayama A, Hoshi M, Saito H, Kamamoto S, Tanaka M, Kawashima M, Mamada H, Kusumi E, Sapkota B, Shrestha S, Shrestha R, Bhandari D, Sawano T, Yamashita E, Tanimoto T, Ozaki A
First Author:
Murayama A
Journal/Book:
Respiration
URL:
Evaluation of Financial and Non-financial Conflicts of Interest and Quality of Evidence underlying Psoriatic Arthritis Clinical Practice Guidelines–Analysis of Personal Payments from Pharmaceutical Companies and Authors’ Self-citation Rate in Japan and the United States
No.
Date:
Title:
50
Authors:
Mamada H, Murayama A, Kamamoto S, Kaneda Y, Yoshida M, Sugiura S, Yamashita E, Kusumi E, Saito H, Sawano T, Tanimoto T, Vassar M, Ozieranski P, Ozaki A
First Author:
Mamada H
Journal/Book:
Arthritis Care Res (Hoboken)
URL:
Trend in industry payments to rheumatologists in the United States during the COVID-19 pandemic between 2013 and 2021
No.
Date:
Title:
49
Authors:
Murayama A, Kamamoto S, Higuchi K, Shigeta H, Ozaki A
First Author:
Murayama A
Journal/Book:
J Rheumatol
URL:
Undisclosed financial conflicts of interest with pharmaceutical companies among the authors of the Esophageal Cancer Practice Guidelines 2017 by the Japan Esophageal Society
No.
Date:
Title:
48
Authors:
Murayama A, Kamamoto S, Shigeta H, Saito H, Yamashita E, Tanimoto T, Ozaki A
First Author:
Murayama A
Journal/Book:
Dis Esophagus
URL:
Industry Payments to Allergists and Clinical Immunologists in the United States during the COVID-19 pandemic
No.
Date:
Title:
47
Authors:
Murayama A, Kamamoto S, Saito H, Tanimoto T, Ozaki A
First Author:
Murayama A
Journal/Book:
Ann Allergy Asthma Immunol
URL:
Evaluation of financial relationships between Japanese certified pediatric hematologist/oncologists and pharmaceutical companies: a cross-sectional analysis of personal payments from pharmaceutical companies between 2016 and 2019
No.
Date:
Title:
46
Authors:
Kamamoto S, Murayama A, Kusumi E, Yoshida M, Saito H, Sawano T, Yamashita E, Tanimoto T, Ozaki A
First Author:
Kamamoto S
Journal/Book:
Pediatr Blood Cancer
URL:
Trend in industry payments to infectious disease physicians in the United States: a seven-year analysis of non-research payments from Open Payments Database between 2014 and 2020
No.
Date:
Title:
45
Authors:
Murayama A, Nakano K, Kamamoto S, Sato M, Saito H, Tanimoto T, Ozaki A
First Author:
Murayama A
Journal/Book:
Clin Microbiol Infect
URL:
Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019
No.
Date:
Title:
44
Authors:
Murayama A, Kamamoto S, Saito H, Yamada K, Bhandari D, Shoji I, Mamada H, Kawashima M, Yamashita E, Kusumi E, Sawano T, Sapkota B, Tanimoto T, Ozaki A
First Author:
Murayama A
Journal/Book:
Int J Environ Res Public Health
URL:
Gap analysis in manufacturing, innovation and marketing of medical devices in the Asia-Pacific region
No.
Date:
Title:
43
Authors:
Sapkota B, Palaian S, Shrestha S, Ozaki A, Izham MIM Ibrahim, Jakovljevic M
First Author:
Sapkota B
Journal/Book:
Expert Rev Pharmacoecon Outcomes Res
URL:
Evaluation of Conflicts of Interest among Participants of the Japanese Nephrology Clinical Practice Guideline
No.
Date:
Title:
42
Authors:
Murayama A, Yamada K, Yoshida M, Kaneda Y, Saito H, Sawano T, Shrestha S, Shrestha R, Tanimoto T, Ozaki A
First Author:
Murayama A
Journal/Book:
Clin J Am Soc Nephrol
URL:
A collaboration between physicians and journalists to create unbiased health information
No.
Date:
Title:
41
Authors:
Senoo Y, Ozaki A, Watanabe M, Tanimoto T
First Author:
Senoo Y
Journal/Book:
BMJ
URL:
Pharmaceutical payments to Japanese certified hematologists: a retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019
No.
Date:
Title:
40
Authors:
Kusumi E, Murayama A, Kamamoto S, Kawashima M, Yoshida M, Saito H, Sawano T, Yamashita E, Tanimoto T, Ozaki A
First Author:
Kusumi E
Journal/Book:
Blood Cancer J
URL:
An Assessment of adherence to the WHO-delineated Good Manufacturing Practice by the pharmaceutical companies in Kabul, Afghanistan
No.
Date:
Title:
39
Authors:
Roien R, Shrestha R, Yadav K, Ozaki A, Ahmadi MB, kaneda Y, Kotera Y, Sapkota B, Shrestha S
First Author:
Roien R
Journal/Book:
Cost Effectiveness and Resource Allocation
URL:
The Diovan scandal in Japan; don’t let bygones be bygones
No.
Date:
Title:
38
Authors:
Murata N, Ozaki A, Murayama A, Sawano T, Tanimoto T
First Author:
Murata N
Journal/Book:
J Hum Hypertens
URL:
Awareness and perceptions among members of a Japanese cancer patient advocacy group concerning the financial relationships between the pharmaceutical industry and physicians
No.
Date:
Title:
37
Authors:
Murayama A, Senoo Y, Harada K, Kotera Y, Saito H, Sawano T, Suzuki Y, Tanimoto T, Ozaki A
First Author:
Murayama A
Journal/Book:
IJERPH
URL:
Generic Medicine and Generic Prescribing in Nepal: An implication for policymakers
No.
Date:
Title:
36
Authors:
Shrestha R, Shrestha S, Sapkota B, Thapa S, Ansari M, Khatiwada AP, Roien R, Ozaki A
First Author:
Shrestha R
Journal/Book:
Journal of Multidisciplinary Healthcare
URL:
How Do Institutional Conflicts of Interest Between Pharmaceutical Companies and the Healthcare Sector Become Corrupt? A Case Study of Scholarship Donations Between Department of Clinical Anesthesiology, Mie University, and Ono Pharmaceutical in Japan
No.
Date:
Title:
35
Authors:
Ozaki A, Murayama A, Harada K, Saito H, Sawano T, Tanimoto T, Ozieranski P
First Author:
Ozaki A
Journal/Book:
Frontiers in Public Health
URL:
Are Clinical Practice Guideline for Hepatitis C by the American Association for the Study of Liver Disease and Infectious Diseases Society of America Evidence-based? Financial Conflicts of Interest and Assessment of Quality of Evidence and Strength of Recommendations
No.
Date:
Title:
34
Authors:
Murayama A, Ozaki A, Saito H, Sawano T, Tanimoto T
First Author:
Murayama A
Journal/Book:
HEPATOLOGY
URL:
Evaluation of Financial Conflicts of Interest and Drug Statements in the Coronavirus Disease 2019 Clinical Practice Guideline in Japan
No.
Date:
Title:
33
Authors:
Hashimoto T, Murayama A, Mamada H, Saito H, Tanimoto T, Ozaki A
First Author:
Hashimoto T
Journal/Book:
Clin Microbiol Infect
URL:
Financial and Intellectual Conflicts of Interest Among Japanese Clinical Practice Guidelines Authors for Allergic Rhinitis
No.
Date:
Title:
31
Authors:
Murayama A, Kida F, Ozaki A, Saito H, Sawano T, Tanimoto T
First Author:
Murayama A
Journal/Book:
Otolaryngol Head Neck Surg
URL:
Japan’s conditional early approval program for innovative cancer drugs: Comparison of the regulatory processes with the US FDA and the EMA
No.
Date:
Title:
30
Authors:
Murayama A, Ueda M, Shrestha S, Tanimoto T, Ozaki A
First Author:
Murayama A
Journal/Book:
Cancer Cell
URL:
The Coverage in England of US-Approved Cancer Drugs
No.
Date:
Title:
29
Authors:
Hashimoto T, Ozaki A, Tanimoto T
First Author:
Hashimoto T
Journal/Book:
JAMA Internal Medicine
URL:
A critical appraisal of Japan's new drug approval process: a case study of FLT3-ITD inhibitor quizartinib
No.
Date:
Title:
32
Authors:
Kidoguch K, Shibusawa M, Tanimoto T
First Author:
Kidoguch K
Journal/Book:
Invest New Drugs
URL:
Industry Payments to Medical Oncologists
No.
Date:
Title:
28
Authors:
Hashimoto T, Ozaki A, Tanimoto T
First Author:
Hashimoto T
Journal/Book:
JAMA Oncology
URL:
Japan’s Drug Regulation During the COVID‐19 Pandemic: Lessons From a Case Study of Favipiravir
No.
Date:
Title:
27
Authors:
Ueda M, Tanimoto T, Murayama A, Ozaki A, Kami M
First Author:
Ueda M
Journal/Book:
Clin Pharmacol Ther
URL:
Opioids: A ‘crisis’ of too much or not enough – or simply how rich you are and where you live?
No.
Date:
Title:
26
Authors:
Miyachi T, Ozaki A, Saito H, Sawano T, Tanimoto T, Crump A
First Author:
Miyachi T
Journal/Book:
Eur J Pain
URL:
Whistleblowing and Misconduct at Large Pharmaceutical Firms
No.
Date:
Title:
25
Authors:
Hashimoto T, Ozaki A, Tanimoto T
First Author:
Hashimoto T
Journal/Book:
The Journal of the American Medical Association
URL:
Pharmaceutical company payments to authors of the Japanese guidelines for the management of hypertension
No.
Date:
Title:
24
Authors:
Senoo Y, Hiroaki S, Ozaki A, Sawano T, Shimada Y, Yamamoto K, Suzuki Y, Tanimoto T
First Author:
Senoo Y
Journal/Book:
Medicine
URL:
Financial payments made by pharmaceutical companies to the authors of Japanese hematology clinical practice guidelines between 2016 and 2017
No.
Date:
Title:
23
Authors:
Harada K, Ozaki A, Saito H, Sawano T, Yamamoto K, Murayama A, Senoo Y, Tanimoto T
First Author:
Harada K
Journal/Book:
Health Policy
URL:
Financial payments made by pharmaceutical companies to the authors of Japanese hematology clinical practice guidelines between 2016 and 2017
No.
Date:
Title:
22
Authors:
Kayo Harada, Akihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, Kana Yamamoto, Anju Murayama, Yuki Senoo, Tetsuya Tanimoto
First Author:
Kayo Harada
Journal/Book:
Health Policy
URL:
Covid-19 experts appearing on Japanese television: their characteristics and financial conflicts of interest with pharmaceutical companies.
No.
Date:
Title:
20
Authors:
Anju Murayama, Akihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, Ranjit Sah, Tetsuya Tanimoto
First Author:
Anju Murayama
Journal/Book:
Clinical Microbiology and Infection
URL:
Pharmaceutical company payments to authors of the Japanese Clinical Practice Guidelines for Hepatitis C treatment
No.
Date:
Title:
21
Authors:
Kida Futa, Anju Murayama, Hiroaki Saito, Akihiko Ozaki, Yuki Shimada, Tetsuya Tanimoto
First Author:
Kida Futa
Journal/Book:
Liver International
URL:
Pharmaceutical good manufacturing practice: Leuplin® production in Japan identifies major international shortcomings
No.
Date:
Title:
23
Authors:
Masahiro Wada, Akihiko Ozaki, Takashi Miyachi, Tetsuya Tanimoto, Andy Crump
First Author:
Masahiro Wada
Journal/Book:
Investigational New Drugs
URL:
Transparency is not enough: how can we improve the management of financial conflicts of interest between Pharma and healthcare domains?
No.
Date:
Title:
19
Authors:
Akihiko Ozaki, Anju Murayama, Hiroaki Saito, Toyoaki Sawano, Kayo Harada, Yuki Senoo, Kana Yamamoto, Tetsuya Tanimoto
First Author:
Akihiko Ozaki
Journal/Book:
Clinical Pharmacology & Therapeutics
URL:
Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan
No.
Date:
Title:
17
Authors:
Kana Yamamoto, Anju Murayama, Akihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, Tetsuya Tanimoto
First Author:
Kana Yamamoto
Journal/Book:
International Urogynecology Journal
URL:
Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan
No.
Date:
Title:
16
Authors:
Anju Murayama, Akihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, Yuki Shimada, Kana Yamamoto, Yosuke Suzuki, Tetsuya Tanimoto
First Author:
Anju Murayama
Journal/Book:
PLOS ONE
URL:
Accuracy of post-publication Financial Conflict of Interest corrections in medical research: a secondary analysis of pharmaceutical company payments to the authors of the CREATE-X trial report in the New England Journal of Medicine
No.
Date:
Title:
18
Authors:
Akihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, Yuki Shimada, Tetsuya Tanimoto
First Author:
Akihiko Ozaki
Journal/Book:
Bioethics
URL:
Response to "Strictness and Transparency in Approval Process of Medical Products: Japanese Situation"
No.
Date:
Title:
15
Authors:
Toyoaki Sawano, Akihiko Ozaki, Hiroaki Saito, Yuki Shimada, Tetsuya Tanimoto
First Author:
Toyoaki Sawano
Journal/Book:
Clinical Pharmacology & Therapeutics
URL:
Overview and Transparency of Non-research Payments to Healthcare Organizations and Healthcare Professionals from Pharmaceutical Companies in Japan: Analysis of Payment Data in 2016
No.
Date:
Title:
14
Authors:
Akihiko Ozaki, Hiroaki Saito, Yuki Senoo, Toyoaki Sawano, Yuki Shimada, Yurie Kobashi, Kana Yamamoto, Yosuke Suzuki, Tetsuya Tanimoto
First Author:
Akihiko Ozaki
Journal/Book:
Health Policy
URL:
Pharmaceutical company payments to Japanese government drug regulation committee members
No.
Date:
Title:
13
Authors:
Sawano T, Ozaki A, Saito H, Shimada Y, Tanimoto T
First Author:
Toyoaki Sawano
Journal/Book:
Clinical Pharmacology & Therapeutics
URL:
Pharmaceutical Company Payments to the Professors of Orthopaedic Surgery Departments in Japan
No.
Date:
Title:
12
Authors:
Hiroaki Saito, Akihiko Ozaki, Toyoaki Sawano, Yuki Shimada, Kana Yamamoto, Yosuke Suzuki, Tetsuya Tanimoto
First Author:
Hiroaki Saito
Journal/Book:
Journal of Bone and Joint Surgery
URL:
Japan's drug regulation framework: aiming for better health or bigger profits
No.
Date:
Title:
11
Authors:
Akihiko Ozaki, Yuki Senoo, Hiroaki Saito, Andy Crump, Tetsuya Tanimoto
First Author:
Akihiko Ozaki
Journal/Book:
International Journal of Health Policy and Management
URL:
Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
No.
Date:
Title:
10
Authors:
Yurie Kobashi, Makoto Watanabe, Hideaki Kimura, Asaka Higuchi, Akihiko Ozaki
First Author:
Yurie Kobashi
Journal/Book:
International Journal of Health Policy and Management
URL:
Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis
No.
Date:
Title:
9
Authors:
Akihiko Ozaki, Hiroaki Saito, Yosuke Onoue, Toyoaki Sawano, Yuki Shimada, Yurie Somekawa, Aritsune Tsuji, Tetsuya Tanimoto
First Author:
Akihiko Ozaki
Journal/Book:
BMJ Open
URL:
Financial ties between authors of the clinical practice guidelines and pharmaceutical companies: an example from Japan
No.
Date:
Title:
8
Authors:
Hiroaki Saito, Yuta Tani, Akihiko Ozaki, Toyoaki Sawano, Yuki Shimada, Kana Yamamoto, Tetsuya Tanimoto
First Author:
Hiroaki Saito
Journal/Book:
Clinical Microbiology and Infection
URL:
Payments From Pharmaceutical Companies to Authors Involved in the Valsartan Scandal in Japan
No.
Date:
Title:
7
Authors:
Toyoaki Sawano, Akihiko Ozaki, Hiroaki Saito, Yuki Shimada, Tetsuya Tanimoto
First Author:
Toyoaki Sawano
Journal/Book:
JAMA Network Open
URL:
Transparency of clinical evidence for medical devices in Europe
No.
Date:
Title:
6
Authors:
Tetsuya Tanimoto, Hiroaki Saito, Toyoaki Sawano, Yuki Shimada, Akihiko Ozaki
First Author:
Tetsuya Tanimoto
Journal/Book:
Lancet
URL:
Evaluation of pharmaceutical company payments and conflict of interest disclosures among oncology clinical practice guideline authors in Japan
No.
Date:
Title:
5
Authors:
Hiroaki Saito, Akihiko Ozaki, Toyoaki Sawano, Yuki Shimada, Tetsuya Tanimoto
First Author:
Hiroaki Saito
Journal/Book:
JAMA Network Open
URL:
Pharmaceutical company payments to executive board members of professional medical associations in Japan
No.
Date:
Title:
4
Authors:
Hiroaki Saito, Akihiko Ozaki, Yasuma Kobayashi, Toyoaki Sawano, Tetsuya Tanimoto
First Author:
Hiroaki Saito
Journal/Book:
JAMA Internal Medicine
URL:
Pharmaceutical company payments to the authors of the Japanese dementia clinical practice guidelines in 2016
No.
Date:
Title:
3
Authors:
Yuki Shimada, Akihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, Tetsuya Tanimoto
First Author:
Yuki Shimada
Journal/Book:
Alzheimer's & Dementia: Translational Research & Clinical Interventions
URL:
A call for improved transparency in financial aspects of clinical trials: a case study of the CREATE-X trial in the New England Journal of medicine
No.
Date:
Title:
2
Authors:
Akihiko Ozaki, Morihito Takita, Tetsuya Tanimoto
First Author:
Akihiko Ozaki
Journal/Book:
Investigational New Drugs
URL:
Conflict of interest and the CREATE-X trial in the New England Journal of medicine
No.
Date:
Title:
1
Authors:
Akihiko Ozaki
First Author:
Akihiko Ozaki
Journal/Book:
Science and Engineering Ethics
URL: